NCT00632086View on ClinicalTrials.gov

Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

PA32540

DRUG

aspirin component of PA32540

The 325 mg aspirin component of PA32540

DRUG

Ecotrin

325 mg Ecotrin

Sponsors

Lead Sponsor

POZEN
All Listed Sponsors
lead

POZEN

INDUSTRY

NCT00632086 - Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers | Biotech Hunter | Biotech Hunter